Viracta Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $738 |
Gross Profit | -96 | -110 | 615 |
EBITDA | -9,037 | -8,173 | -12,693 |
EBIT | -9,133 | -8,283 | -12,816 |
Net Income | -9,830 | -9,141 | -13,765 |
Net Change In Cash | 0 | 0 | 738 |
Free Cash Flow | -9,827 | -7,849 | -10,027 |
Cash | 13,981 | 12,062 | 12,317 |
Basic Shares | 39,404 | 39,323 | 38,790 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $120 |
Gross Profit | -492 | -210 | -178 | 88 |
EBITDA | -46,862 | -50,379 | -114,093 | -18,769 |
EBIT | -47,354 | -50,589 | -114,271 | -18,801 |
Net Income | -51,058 | -49,774 | -203,062 | -19,199 |
Net Change In Cash | 0 | 0 | 0 | 120 |
Cost of Revenue | -66,781 | 56,465 | 2,149 | |
Free Cash Flow | -40,030 | -35,502 | -23,103 | -16,109 |
Cash | 12,317 | 36,773 | 103,554 | 47,089 |
Basic Shares | 38,624 | 37,790 | 31,870 | 92 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.27 |
2024-06-30 | -$0.25 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.35 |
